If ongoing research continues to deliver strong results, Cagrilintide could soon become part of the standard toolkit for treating obesity and metabolic disease, especially as a dual-therapy option alongside GLP-1s
The medication stimulates glucose-dependent insulin secretion, suppresses glucagon, and slows gastric emptying to regulate blood glucose
GLP-1 medications (semaglutide/Wegovy, tirzepatide/Zepbound) have become incredibly popular for women dealing with midlife weight gain
Around 85% of people experience plateaus due to metabolic changes, dosage needs, muscle loss, hidden calories, reduced activity, hormonal shifts, or your bodys natural weight "set point." Heres why it happens and how to overcome it: Metabolism slows down as you lose weight
This natural, sustainable approach can be used as an alternative or alongside other solutions to combat rebound weight gain and digestive discomfort. 2